Tag: Reveals

Categories
Business

China box-office file reveals international pent-up demand for films

China box-office record reveals global pent-up demand for movies

Imax broke its box office records over the weekend of the New Year celebrations in China and the results predict what will happen when more US theaters resume operations this summer, CEO Rich Gelfond told CNBC on Tuesday.

The company, which produces immersive movie experiences, said it grossed $ 25 million between Friday and Sunday, up 45% from its pre-pandemic record.

“It tells you [that] If it’s safe to go outside and people want to go, run to the movies, “said Gelfond, who appeared on Closing Bell after the deal on Wall Street ended.

Detective Chinatown 3, a comedy adventure postponed from the release of Lunar New Year last year, captured a large portion of Imax ticket sales during the three-day period. The film grossed $ 23.5 million, the best results Imax has ever seen for a Chinese film. The action films “A Writer’s Odyssey” and “New Gods: Nezha Reborn” have also helped Imax hit both gross admissions and gross sales highs.

Coming from the news, Imax shares rose more than 6% on Tuesday, the best day since November. The stock closed at $ 19.85, up more than 5% after hours.

Imax took in more than 1 million people in cinemas in China on Friday, the best one-day attendance ever recorded. The results come despite capacity constraints that persist in entertainment businesses in China. The $ 25 million Imax brought in at the box office was better than the comparable opening week of 2019 that preceded the coronavirus pandemic.

Most theaters in China have a 75% capacity limit, while parts of the country with higher broadcasts of Covid-19 are limited to 50%. US theater restrictions vary by state. Limitations range from 25% capacity in Minnesota to 50% in Indiana to 100% in Alaska. This is based on data held by the National Association of Theater Owners.

The seven-day New Year holiday ends on Wednesday. Theaters in China closed around this time last year when the country shut down in response to the fast-spreading virus discovered in Wuhan city, Hubei province in late 2019.

The movie frenzy was fueled by China’s traditional travel season, which has largely been suspended due to coronavirus restrictions. Millions of time spent in the cinema with scrapped travel plans.

Gelfond said Imax expected strong participation in China over the weekend.

“I think the only thing you can say is the pent-up demand that people just get tired of sitting on their couches and watching streaming or whatever else they’ve been doing,” he said. “I think they are just happy to get out and I think that gives the rest of the world a guess.”

In the midst of the pandemic, Imax’s 2020 sales fell 74% from the first three quarters of last year through September. The company is expected to report fourth quarter and full year 2020 performance next month.

Gelfond said in December that the release of US films in 2021, including a number of films postponed from first releases last year, would be an “embarrassment of fortune” for Imax if the country’s theaters closed Should be opened at the beginning of the year.

According to the online ticketing platform Maoyan Entertainment, mainland China posted holiday week sales of 6.77 billion yuan, or $ 1.05 billion, on Tuesday. That figure surpassed the record 5.9 billion yuan in the same period of 2019.

Since the theaters reopened in June, box office revenues have increased. Coronavirus cases have declined sharply in countries like China, Australia and South Korea, and movie ticket sales have increased.

Global movie ticket sales decreased 70% year over year in 2020. Ticket sales in the Asia-Pacific region accounted for approximately 51% of global sales, up from 41% in 2019, based on information from Comscore and Gower Street. The US and Canadian box office sales accounted for just 18% of sales in 2020, compared to 30% in 2019.

– Reuters contributed to this report.

Categories
Health

Tony Bennett Reveals He Has Alzheimer’s Illness

Tony Bennett Reveals He Has Alzheimer’s Disease

Bennett, who had a career spanning seven decades, scored his first major success in 1951: “Because of you.” In 1962 he recorded “I Left My Heart in San Francisco” which became his trademark. Long after other pop singers died or faded from the waves, Bennett experienced a revival in popularity: He won a Grammy in 1994 for his album “Tony Bennett: MTV Unplugged”. Since then, he has recorded duets with a number of personalities, including James Taylor, Sting and Amy Winehouse.

In 2014 he recorded an album with Lady Gaga, Tony Bennett & Lady Gaga: Cheek to Cheek, which debuted at # 1 on the Billboard Top 200 Pop and Rock Charts. According to the AARP article, a follow-up album with Lady Gaga will be released this spring, which was recorded between 2018 and early 2020.

Lady Gaga was aware of Bennett’s condition when they recorded their last collaboration, the article says. In documentaries from the sessions, Bennett rarely speaks and offers one-word answers such as “thank you” or “yes”.

But his appetite for everything musical remains robust. According to the magazine, he continues to rehearse a 90-minute set twice a week with longtime pianist Lee Musik – without the interruption that can characterize his speech.

According to the Alzheimer’s Association, more than five million Americans live with Alzheimer’s, including one in ten people age 65 and over. Symptoms can initially include repeating questions, losing in familiar places, or misplacing things, and eventually hallucinations, angry outbursts, and the inability to recognize family and friends or even to communicate. Alzheimer’s is not curable.

Susan Bennett serves as her husband’s caregiver.

“I have my moments and it’s going to be very difficult,” she told the magazine. “It’s not fun to argue with someone who doesn’t understand you.” But she added that they felt happier than many other people living with Alzheimer’s.

Categories
Business

EU piles stress on AstraZeneca over delayed vaccines, reveals particulars of contract

EU piles pressure on AstraZeneca over delayed vaccines, reveals details of contract

The President of the European Commission, Ursula von der Leyen, will give a lecture at the end of a video conference of the members of the European Council that dealt with the Covid 19 pandemic in Brussels on January 21, 2021.

OLIVIER HOSLET | AFP | Getty Images

LONDON – The European Union released an edited version of the contract it signed with AstraZeneca on Friday as the bloc put pressure on the drug maker to deliver the promised Covid vaccine shipments.

The EU, which has been criticized for its slow adoption of vaccinations, was hit with a blow by AstraZeneca last week when the company said it could only deliver a fraction of the shots it agreed to for the first quarter.

AstraZeneca has denied it failed to deliver on its commitments, stating that shipments to the 27-nation bloc were targets rather than promises. The company also cited production problems at its European plants for the delays.

The European Commission, the EU executive, welcomed AstraZeneca’s commitment to greater transparency after the company agreed to publish details of the agreement. AstraZeneca was not immediately available to leave comments when CNBC contacted them.

The contract, which was signed on August 27, provides for AstraZeneca to undertake to the best of its ability to build capacity to produce 300 million doses of vaccine, with the Commission having the option to order an additional 100 million doses.

In the case of AstraZeneca, the agreement defines “best effort” as the activities a company with similar resources would undertake in the development and manufacture of its vaccine.

This includes “bearing in mind the urgent need for a vaccine to end a global pandemic that is creating serious public health problems, restrictions on personal freedoms and economic impacts around the world, but considering its effectiveness and safety”.

The contract states that AstraZeneca will use its “best possible efforts” to manufacture the vaccine at manufacturing facilities in the EU. The deal also provides for this to include plants based in the UK, although the country left the bloc last year.

AstraZeneca has been told to send some of the UK-made cans to the block, but the company said a separate deal with the UK prevented that.

The European Medicines Agency is expected to make a decision on Friday on whether the AstraZeneca vaccine will actually be approved for use.

International Competition Concerns

The President of the European Commission, Ursula von der Leyen, said on Friday morning on German radio: “There are binding orders and the contract is crystal clear.”

“AstraZeneca also explicitly assured us in this contract that no other obligations would prevent the fulfillment of the contract,” she said, according to Reuters.

Von der Leyen of the EU claimed the deal included clear delivery amounts for December and the first three quarters of 2021.

Earlier this week, Pascal Soriot, CEO of AstraZeneca, said the EU contract was based on what is known as a “best effort” clause and did not officially oblige the drug maker to a specific delivery schedule.

The EU von der Leyen rejected this proposal on Friday, adding that the clause would only apply if it was unclear whether AstraZeneca could develop a safe and effective vaccine. She also claimed that the contract specifically mentioned four manufacturing facilities that would supply the vaccine to Europe, two of which are in the UK.

A look at the headquarters of the British-Swedish multinational pharmaceutical and biopharmaceutical company AstraZeneca as a Covid-19 vaccine developed by AstraZeneca and inspected in Brussels, Belgium on January 28, 2021.

Dursun Aydemir | Anadolu Agency | Getty Images

EU officials have indicated that deliveries from the UK to Europe could be rerouted if delays in European production persist.

UK Prime Minister Boris Johnson said he remained “confident” of delivering the AstraZeneca vaccine developed in partnership with Oxford University. Johnson added that he was “very pleased” that the country was among the fastest in Europe to introduce the vaccine.

The UK has the second highest number of confirmed Covid cases in Europe after Russia, recording the highest number of coronavirus-related deaths of any European nation and the fifth highest worldwide.

The EU of around 450 million people is struggling to get its vaccinations up and running as it is insufficiently supplied and is currently lagging far behind countries like Israel and the UK in delivering vaccines to its citizens.

Vaccine maker Pfizer-BioNTech initially delivered a blow, announcing it would temporarily cut production to improve its production capacity in Belgium. This was followed by AstraZeneca last Friday, which reduced its delivery estimates for the region.

An unnamed senior EU official told Reuters that the bloc expected about 80 million doses by March but had been told it would only receive 31 million doses instead. The company has not confirmed the quantities concerned.

A deepening dispute between the EU and AstraZeneca has raised concerns about international competition for limited vaccine supplies. Hopefully the vaccinations can help end the coronavirus pandemic.

– CNBC’s Holly Ellyatt contributed to this report.

Categories
Business

Jay Leno reveals what he thinks is the genius behind Elon Musk, Tesla

Jay Leno reveals what he thinks is the genius behind Elon Musk, Tesla

Jay Leno said he thinks the genius of Tesla CEO Elon Musk was that “he built the infrastructure while he built the vehicle”.

“Even today, many major manufacturers build an electric car, but where do you charge it?” Leno told The News with Shepard Smith during a Friday night interview. “Elon was smart when he started, he knew this idea would work, so he built charging stations.”

Electric car maker Tesla will be the newest member of the S&P 500 on Monday.

2020 was a monster year for Tesla, the sixth largest company in the world – its inventory has grown by about 700% that year. CNBC’s “Jay Leno’s Garage” host said he was confident Tesla could maintain its dominance in electric vehicles, adding that he had seen European electric cars fall short.

“You don’t have the range of the Tesla,” Leno said. “They’re not doing it because Tesla is leading the field. We seem to have this inferiority complex that things in Europe are somehow better than the things that were built here.”

Leno gave host Shepard Smith examples of superior American innovation, including General Motors’ Corvette, which he believes rivals the Lamborghini and Ferrari and costs just $ 60,000.

He highlighted America’s dominance in private industry and pointed to Musk’s success in the space industry.

“The fact that Elon can send a rocket into space and land it back on earth for a tenth the price of the US government?” Said Leno. “Well, that’s exactly what the private sector should do – cheaper, faster, more efficiently.”

Leno suggested that those who want to feel the “rumble of a car beneath them” should “buy another car.” He admitted that he loves Ferraris, Ford Cobra and Lamborghinis on weekends, but that sitting in traffic and driving on the spot just isn’t practical.

“When you’re in a quiet electric vehicle, you don’t pollute and save,” Leno said. “When I want to have fun, I take out my 1960 Triumph TR3 and bomb around, but in terms of everyday vehicles you can’t beat it.” [the Tesla]. “

Categories
Health

A European Official Reveals a Secret: The U.S. Is Paying Extra for Coronavirus Vaccines

A European Official Reveals a Secret: The U.S. Is Paying More for Coronavirus Vaccines

This is significantly lower than the company’s official price, which was announced at $ 19.50 per dose, which the US government has also paid. The Pfizer vaccine launch began this week in the United States.

The Moderna vaccine, which is the next to be approved for the EU on January 6 and is expected to receive emergency approval by the U.S. Food and Drug Administration on Friday, costs the EU $ 18 per dose, as the table shows. The company said it would charge $ 25 to $ 37 per dose. The US government was directly involved in funding the development of the Moderna vaccine and has signed a contract to pay around $ 15 per dose.

Covid19 vaccinations>

Answers to your vaccine questions

With a coronavirus vaccine spreading out of the US, here are answers to some questions you may be wondering about:

    • If I live in the US, when can I get the vaccine? While the exact order of vaccine recipients may vary from state to state, most doctors and residents of long-term care facilities will come first. If you want to understand how this decision is made, this article will help.
    • When can I get back to normal life after the vaccination? Life will only get back to normal once society as a whole receives adequate protection against the coronavirus. Once countries have approved a vaccine, they can only vaccinate a few percent of their citizens in the first few months. The unvaccinated majority remain susceptible to infection. A growing number of coronavirus vaccines show robust protection against disease. However, it is also possible that people spread the virus without knowing they are infected because they have mild symptoms or no symptoms at all. Scientists don’t yet know whether the vaccines will also block the transmission of the coronavirus. Even vaccinated people have to wear masks for the time being, avoid the crowds indoors and so on. Once enough people are vaccinated, it becomes very difficult for the coronavirus to find people at risk to become infected. Depending on how quickly we as a society achieve this goal, life could approach a normal state in autumn 2021.
    • Do I still have to wear a mask after the vaccination? Yeah, but not forever. Here’s why. The coronavirus vaccines are injected deep into the muscles and stimulate the immune system to produce antibodies. This seems to be sufficient protection to protect the vaccinated person from disease. What is not clear, however, is whether it is possible for the virus to bloom in the nose – and sneeze or exhale to infect others – even if antibodies have been mobilized elsewhere in the body to prevent that vaccinated person gets sick. The vaccine clinical trials were designed to determine if people who were vaccinated are protected from disease – not to find out if they can still spread the coronavirus. Based on studies of flu vaccines and even patients infected with Covid-19, researchers have reason to hope that people who are vaccinated will not spread the virus, but more research is needed. In the meantime, everyone – including those who have been vaccinated – must imagine themselves as possible silent shakers and continue to wear a mask. Read more here.
    • Will it hurt What are the side effects? The vaccine against Pfizer and BioNTech, like other typical vaccines, is delivered as a shot in the arm. The injection in your arm feels no different than any other vaccine, but the rate of short-lived side effects seems to be higher than with the flu shot. Tens of thousands of people have already received the vaccines, and none of them have reported serious health problems. The side effects, which can be similar to symptoms of Covid-19, last about a day and are more likely to occur after the second dose. Early reports from vaccine trials suggest that some people may need to take a day off because they feel lousy after receiving the second dose. In the Pfizer study, around half developed fatigue. Other side effects occurred in at least 25 to 33 percent of patients, sometimes more, including headache, chills, and muscle pain. While these experiences are not pleasant, they are a good sign that your own immune system is having a strong response to the vaccine that provides lasting immunity.
    • Will mRNA vaccines change my genes? No. Moderna and Pfizer vaccines use a genetic molecule to boost the immune system. This molecule, known as mRNA, is eventually destroyed by the body. The mRNA is packaged in an oily bubble that can fuse with a cell, allowing the molecule to slide inside. The cell uses the mRNA to make proteins from the coronavirus that can stimulate the immune system. At any given moment, each of our cells can contain hundreds of thousands of mRNA molecules that they produce to make their own proteins. As soon as these proteins are made, our cells use special enzymes to break down the mRNA. The mRNA molecules that our cells make can only survive a few minutes. The mRNA in vaccines is engineered to withstand the cell’s enzymes a little longer, so the cells can make extra viral proteins and trigger a stronger immune response. However, the mRNA can hold for a few days at most before it is destroyed.

Eric Mamer, a spokesman for the European Commission, declined to comment on the price list as the negotiated agreements were “kept confidential” but did not contest the pricing.

A spokeswoman for Ms De Bleeker said she tweeted the details to settle a political debate in Belgium in which opposition officials accuse the government of not providing enough money to buy the vaccines.

“We tried to be transparent, but it seems we were a little too transparent,” said Bavo De Mol, the spokesman.

Several health economists have found that the price of the vaccine itself – even if the US is paying more than Europe – is trivial compared to the economic cost of an ongoing pandemic. Just this week, Congress is preparing to approve payments of $ 600 to each American adult to cushion the blow of the pandemic-sparked recession, far more than the $ 39 per person required are to vaccinate adults at the higher Pfizer price.

“The cost of overpayment is so small compared to potential counterfactual factors,” said Benedic Ippolito, an American Enterprise Institute-based researcher who studies drug prices. “It’s like a shrug when our price is a little higher. This is a one-time pandemic and we will deal with the drug price situation later. “